Key Highlights

  • Third-quarter sales were USD 692,280 versus USD 1,514,817.
  • Operating expenses fell to USD 1.6 million from USD 17.2 million.
  • Net loss was USD 2.6 million versus USD 33.6 million.
  • Loss per share was USD 0.46 versus USD 7.82.

Bonk, Inc. (NASDAQ:BNKK) reported third-quarter 2026 sales of USD 692,280 versus USD 1,514,817 and a Gross Profit of USD 1,613 versus USD 543,142. Total operating expenses fell to USD 1,626,519 from USD 17,215,566. The net loss was USD 2,561,225 versus USD 33,581,216, and net loss attributable to common stockholders was USD 3,675,603.

The loss per share attributed to common shareholders was USD 0.46 versus USD 7.82 a year earlier.

Nine-month gross profit of USD 3,985,708 stands far above the third-quarter figure of USD 1,613, which indicates how uneven results were across the first nine months. Net loss attributable to common stockholders was larger than the net loss because of preferred stock effects.

Nine-Month Results

For nine months, sales were USD 2,271,548 versus USD 1,601,865 and gross profit was USD 3,985,708 versus USD 588,008. Operating expenses were USD 6,271,700 versus USD 26,990,405, and the net loss was USD 10,444,540 versus USD 25,533,204. Loss per share was USD 1.45 versus USD 8.83.

Net loss attributable to common stockholders for nine months was USD 11,558,918. Weighted average shares were about 8.0 million for the quarter and nine months.

Marketable securities and Equity securities held at year-end were no longer on the Balance Sheet at September 30, and the company recorded common stock issued from stock payable for services of USD 1,663,936.

Company Background

Bonk was formerly Safety Shot and, before that, Jupiter Wellness. In August 2023 it acquired Assets that included the Sure Shot dietary supplement, described in the filing as a "blood alcohol reduction drink", and launched the product in December 2023.

It entered an arrangement agreement with Yerbae Brands Corp. in January 2025, which closed on June 27, 2025, bringing Yerbae's beverage subsidiaries into the group. The filing's litigation notes include a case brought against Yerbae, LLC.

Preferred stock outstanding was 208,000 shares versus 176,806 at year-end, and related party Revenue sharing assets were USD 1,657,735 versus USD 2,060,968.

Balance Sheet and Items to Follow

Cash fell to USD 90,507 at September 30 from USD 2,278,340 at year-end 2025, a net decrease of USD 2,187,833 over the nine months. Total assets were USD 28,007,691 versus USD 40,973,415.

Items to follow include sales recovery, the gross profit level after the third quarter result, operating cost control and the cash position.

The balance sheet shows digital assets of USD 3,368,230 versus USD 630,605 in current assets, inventory of USD 284,018 versus USD 949,275 and a note receivable of USD 6,064,379. Non-current digital assets of USD 17,344,636 at year-end are no longer carried. Goodwill was USD 14,147,778 and total current liabilities were USD 7,032,828, including a USD 3,000,000 STS Digital loan.

Total shareholders' equity was USD 20,974,863 versus USD 34,996,344, with an accumulated Deficit of USD 193,936,719. Cash Flow from investing activities provided USD 6,607,961 while financing used USD 3,951,123, including a USD 4,000,000 Fair Value of treasury stock tied to a Core4 agreement. About 7.94 million common shares were outstanding.